Technology advancement to drive lab automation market through next decade
By Catherine Eckford (European Pharmaceutical Review)
MSD acquisition to accelerate first-in-class COPD drug
By Catherine Eckford (European Pharmaceutical Review)
FDA approves first-of-a-kind oral therapy for rare disease
By Catherine Eckford (European Pharmaceutical Review)
Next drug patent cliff to challenge Big Pharma strategy
By Catherine Eckford (European Pharmaceutical Review)